Many drugs inhibit AP-1 expression and thus improve atherosclerosis and ventricular remodeling after acute myocardial infarction (Yoshiyama et al., 2001; Lin et al., 2015; Chou et al., 2019; Yang et al., 2020). The gene discussed is FOS; the disease is myocardial infarction.